Insider Buying: Odyssey Therapeutics (NASDAQ:ODTX) CFO Acquires 1,000 Shares of Stock

Key Points

  • Odyssey Therapeutics CFO Jason Haas bought 1,000 shares on Friday, May 8th at an average price of $20.00, spending $20,000 total.
  • After the purchase, Haas owned 62,908 shares worth about $1.26 million, and the trade increased his stake by 1.62%.
  • ODTX shares were trading up 6.3%, opening at $17.45, with a 52-week range of $15.35 to $20.30.

Odyssey Therapeutics, Inc. (NASDAQ:ODTX - Get Free Report) CFO Jason Haas bought 1,000 shares of the stock in a transaction on Friday, May 8th. The stock was purchased at an average price of $20.00 per share, for a total transaction of $20,000.00. Following the completion of the purchase, the chief financial officer owned 62,908 shares of the company's stock, valued at approximately $1,258,160. This trade represents a 1.62% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Odyssey Therapeutics Trading Up 6.3%

Shares of ODTX opened at $17.45 on Tuesday. Odyssey Therapeutics, Inc. has a 1 year low of $15.35 and a 1 year high of $20.30.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Odyssey Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Odyssey Therapeutics and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles